Ganoderma lucidum polysaccharide has been shown to ameliorate the microbiota dysregulation induced by AOM/DSS, enhance the production of short-chain fatty acids, and downregulate the expression of COX-2, IL-1β, and inducible nitric oxide synthase (iNOS) [20]. Here, NOS2 is linked to infectious otitis media.